Ad
related to: oxybutynin wikipedia biography search people database name
Search results
Results From The WOW.Com Content Network
Oxybutynin, sold under the brand name Ditropan among others, is an anticholinergic medication primarily used to treat overactive bladder. It is widely considered a first-line therapy for overactive bladder due to its well-studied side effect profile, broad applicability, and continued efficacy over long periods of time.
This page was last edited on 18 February 2006, at 23:39 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
IGDB (Internet Games Database) IMDb (Internet Movie Database) INDUCKS; IndexMaster; Informit (database) Inorganic Crystal Structure Database; Interment.net
Overactive bladder affects approximately 11% of the population and more than 40% of people with overactive bladder have incontinence. [5] [6] Conversely, about 40% to 70% of urinary incontinence is due to overactive bladder. [7] Overactive bladder is not life-threatening, [1] but most people with the condition have problems for years. [1]
Here are links to possibly useful sources of information about Oxybutynin. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC
This page was last edited on 11 October 2024, at 02:28 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
United Online CEO Mark Goldston said the acquisition of "The Names Database is a great addition to Classmates.com and furthers our overall mission of connecting people." [ 9 ] As of 2013, United Online no longer mentions the company in its Form 10-K annual report, except once to say it "excludes" in its "active accounts" calculation.
This greatly expanded and improved version of the database included 1344 approved small molecule drugs and 123 biotech drugs as well as 3037 unique drug targets. Version 2.0 also included, for the first time, withdrawn drugs and illicit drugs , extensive food-drug and drug-drug interactions as well as ADMET (absorption, distribution, metabolism ...